Trial of Photodyamic Therapy for Port Wine Stains (capillary hemangioma) with Talaporfin Sodium

Trial of Photodyamic Therapy for Port Wine Stains (capillary hemangioma) with Talaporfin Sodium - Trial of Photodyamic therapy for Port Wine Stains (capillary hemangioma) with Talaporfin Sodium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000684

Enrollment

Registered

2007-04-18

Start date

2007-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

capillary hemangioma

Interventions

After single intervenous bolus injection of Talaporfin Sodium,the capillary hemangioma is irradiated with 664nm diode laser.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patient with capillary hemangioma 2.Patient with capillary hemangioma who has been treated more than 3 months before

Exclusion criteria

Exclusion criteria: 1.Patient with allergy for Talaporfin sodium 2.Patient with hyperphotosensitivity 3.Porphyria 4.Severe liver dysfunction 5.Pregnancy 6.Patient who is taking photosensitive medicine and food 7.Others

Design outcomes

Primary

Measure	Time frame
Safety	—

Secondary

Measure	Time frame
Efficacy	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026